Opportunities and Challenges of Human IPSC Technology in Kidney Disease Research
Human induced pluripotent stem cells (iPSCs), since their discovery in 2007, open a broad array of opportunities for research and potential therapeutic uses. The substantial progress in iPSC reprogramming, maintenance, differentiation, and characterization technologies since then has supported their...
Main Authors: | Jia-Jung Lee, Chuang-Yu Lin, Hung-Chun Chen, Patrick C. H. Hsieh, Yi-Wen Chiu, Jer-Ming Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/12/3232 |
Similar Items
-
Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
by: Zambon, F
Published: (2017) -
Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015) -
MSCs vs. iPSCs: Potential in therapeutic applications
by: Kalaiselvaan Thanaskody, et al.
Published: (2022-11-01) -
Kidney Organoids and Tubuloids
by: Fjodor A. Yousef Yengej, et al.
Published: (2020-05-01) -
Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with <i>PKD1</i> Mutation
by: Aung Khine Linn, et al.
Published: (2022-05-01)